{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:01:00Z","timestamp":1787166060672,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011694","name":"Antibiotic Research UK","doi-asserted-by":"crossref","award":["ANTRUK_SRG 10-2021"],"award-info":[{"award-number":["ANTRUK_SRG 10-2021"]}],"id":[{"id":"10.13039\/100011694","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011694","name":"Antibiotic Research UK","doi-asserted-by":"crossref","award":["ANTRUK_SRG 10-2021"],"award-info":[{"award-number":["ANTRUK_SRG 10-2021"]}],"id":[{"id":"10.13039\/100011694","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011694","name":"Antibiotic Research UK","doi-asserted-by":"crossref","award":["ANTRUK_SRG 10-2021"],"award-info":[{"award-number":["ANTRUK_SRG 10-2021"]}],"id":[{"id":"10.13039\/100011694","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011694","name":"Antibiotic Research UK","doi-asserted-by":"crossref","award":["ANTRUK_SRG 10-2021"],"award-info":[{"award-number":["ANTRUK_SRG 10-2021"]}],"id":[{"id":"10.13039\/100011694","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the UK nearly 54,000 infections were caused by serious resistant bacteria in 2022 but there is a lack of evidence regarding the long-term impact on patients\u2019 lives nor what support they need. This research aimed to answer the question: \u201cWhat are the key elements of experience and support needs of people living with AMR in the UK?\u201d. In-depth semi-structured interviews were undertaken with nine people who had been living with resistant infections or colonisation for 12-months or longer. Interpretive Phenomenological Analysis was used to study the accounts and illustrate individuals\u2019 experiences and support-needs. Participants experienced marginalisation and isolation but also empowerment; described across three major themes: (1) I live in fear and stigma: The long-term impact of AMR; (2) I am battling on my own: A journey toward self-advocacy; and (3) I like to share my story: The role of AMR communities. All participants perceived a lack of knowledge, information, and support from clinicians; difficulties accessing reliable and understandable information; and lack of understanding from family and friends. Charities and online groups provided support with coping with their situation and improving mental health and wellbeing. Understandable and relatable information regarding the science of AMR, transmission, prevention, and living with AMR needs to be provided by clinicians and healthcare services around the time of diagnosis to readily available after diagnosis.<\/jats:p>","DOI":"10.1038\/s41598-024-53814-6","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T22:02:28Z","timestamp":1707516148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Understanding the lived-experience and support-needs of people living with antimicrobial resistance in the UK through interpretative phenomenological analysis"],"prefix":"10.1038","volume":"14","author":[{"given":"Ryan A.","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucina","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,10]]},"reference":[{"key":"53814_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray, C. J. et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 399, 629\u2013655 (2022).","journal-title":"Lancet"},{"key":"53814_CR2","unstructured":"UK Health Security Agency. English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report 2021 to 2022 (2022)."},{"issue":"5","key":"53814_CR3","doi-asserted-by":"publisher","first-page":"e0285170","DOI":"10.1371\/journal.pone.0285170","volume":"18","author":"AN Poudel","year":"2023","unstructured":"Poudel, A. N. et al. The economic burden of antibiotic resistance: A systematic review and meta-analysis. PLoS ONE 18(5), e0285170 (2023).","journal-title":"PLoS ONE"},{"key":"53814_CR4","doi-asserted-by":"publisher","first-page":"e0227139","DOI":"10.1371\/journal.pone.0227139","volume":"15","author":"M Serra-Burriel","year":"2020","unstructured":"Serra-Burriel, M. et al. Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis. PLoS ONE 15, e0227139 (2020).","journal-title":"PLoS ONE"},{"key":"53814_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cmi.2015.12.002","volume":"22","author":"ND Friedman","year":"2016","unstructured":"Friedman, N. D., Temkin, E. & Carmeli, Y. The negative impact of antibiotic resistance. Clin. Microbiol. Infect. 22, 416\u2013422 (2016).","journal-title":"Clin. Microbiol. Infect."},{"key":"53814_CR6","doi-asserted-by":"publisher","first-page":"100033","DOI":"10.1016\/j.infpip.2019.100033","volume":"2","author":"FH Lim","year":"2020","unstructured":"Lim, F. H. et al. An outbreak of two strains of OXA-48 producing Klebsiella pneumoniae in a teaching hospital. Infect. Prev. Pract. 2, 100033 (2020).","journal-title":"Infect. Prev. Pract."},{"key":"53814_CR7","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ajic.2017.11.023","volume":"46","author":"K Currie","year":"2018","unstructured":"Currie, K. et al. Understanding the patient experience of health care\u2013associated infection: A qualitative systematic review. Am. J. Infect. Control 46, 936\u2013942 (2018).","journal-title":"Am. J. Infect. Control"},{"key":"53814_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cmi.2018.10.007","volume":"25","author":"B Rump","year":"2019","unstructured":"Rump, B., Timen, A., Verweij, M. & Hulscher, M. Experiences of carriers of multidrug-resistant organisms: A systematic review. Clin. Microbiol. Infect. 25, 274\u2013279 (2019).","journal-title":"Clin. Microbiol. Infect."},{"issue":"10","key":"53814_CR9","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.ajic.2007.10.007","volume":"35","author":"JD Siegel","year":"2007","unstructured":"Siegel, J. D., Rhinehart, E., Jackson, M. & Chiarello, L. 2007 guideline for isolation precautions: Preventing transmission of infectious agents in health care settings. Am. J. Infect. Control 35(10), S65\u2013S164 (2007).","journal-title":"Am. J. Infect. Control"},{"key":"53814_CR10","unstructured":"UKHSA. Framework of actions to contain Enterobacterales (2022)."},{"key":"53814_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jhin.2020.09.002","volume":"106","author":"LH Wong","year":"2020","unstructured":"Wong, L. H. et al. Empowerment of nurses in antibiotic stewardship: A social ecological qualitative analysis. J. Hosp. Infect. 106, 473\u2013482 (2020).","journal-title":"J. Hosp. Infect."},{"key":"53814_CR12","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.ajic.2019.03.018","volume":"47","author":"O Hereng","year":"2019","unstructured":"Hereng, O., Dinh, A., Salomon, J. & Davido, B. Evaluation in general practice of the patient\u2019s feelings about a recent hospitalization and isolation for a multidrug-resistant infection. Am. J. Infect. Control 47, 1077\u20131082 (2019).","journal-title":"Am. J. Infect. Control"},{"key":"53814_CR13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(99)04196-3","volume":"354","author":"KB Kirkland","year":"1999","unstructured":"Kirkland, K. B. & Weinstein, J. M. Adverse effects of contact isolation. Lancet 354, 1177\u20131178 (1999).","journal-title":"Lancet"},{"key":"53814_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1071\/HI11020","volume":"16","author":"GA Mutsonziwa","year":"2011","unstructured":"Mutsonziwa, G. A. & Green, J. Colonised and isolated: A qualitative metasynthesis of patients\u2019 experiences of being infected with multiple drug resistant organisms and subsequent isolation. Healthc. Infect. 16, 147\u2013155 (2011).","journal-title":"Healthc. Infect."},{"key":"53814_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5172\/conu.2011.180","volume":"39","author":"RL Barratt","year":"2011","unstructured":"Barratt, R. L., Shaban, R. & Moyle, W. Patient experience of source isolation: Lessons for clinical practice. Contemp. Nurse 39, 180\u2013193 (2011).","journal-title":"Contemp. Nurse"},{"key":"53814_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jhin.2017.03.006","volume":"96","author":"BL Slevin","year":"2017","unstructured":"Slevin, B. L., O\u2019Connell, N. H., Treacy, P. & Dunne, C. P. Becoming patient-centred: Sobering insight into CPE-positive patients\u2019 experiences of clinical care. J. Hosp. Infect. 96, 129\u2013130 (2017).","journal-title":"J. Hosp. Infect."},{"key":"53814_CR17","unstructured":"Nussbaum MC. Defense of universal values. In Women and Human Development the Capabilities Approach 34\u201341 (Cambridge University Press, 2020)."},{"key":"53814_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1466-7657.2010.00833.x","volume":"58","author":"H Andersson","year":"2011","unstructured":"Andersson, H., Lindholm, C. & Fossum, B. MRSA\u2014global threat and personal disaster: Patients\u2019 experiences. Int. Nurs. Rev. 58, 47\u201353 (2011).","journal-title":"Int. Nurs. Rev."},{"key":"53814_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jhin.2009.07.002","volume":"73","author":"M Lindberg","year":"2009","unstructured":"Lindberg, M., Carlsson, M., H\u00f6gman, M. & Skytt, B. Suffering from meticillin-resistant Staphylococcus aureus: Experiences and understandings of colonisation. J. Hosp. Infect. 73, 271\u2013277 (2009).","journal-title":"J. Hosp. Infect."},{"key":"53814_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ajic.2012.10.009","volume":"41","author":"S Wiklund","year":"2013","unstructured":"Wiklund, S., Hallberg, U., Kahlmeter, G. & Tammelin, A. Living with extended-spectrum \u03b2-lactamase: A qualitative study of patient experiences. Am. J. Infect. Control 41, 723\u2013727 (2013).","journal-title":"Am. J. Infect. Control"},{"key":"53814_CR21","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.ajic.2018.05.014","volume":"46","author":"S Wiklund","year":"2018","unstructured":"Wiklund, S., \u00d6rtqvist, \u00c5., Berlin, A., Stamm, C. & Broliden, K. Experiences and consequences of living with extended-spectrum \u03b2-lactamase\u2013producing bacteria: A qualitative study. Am. J. Infect. Control 46, 1394\u20131399 (2018).","journal-title":"Am. J. Infect. Control"},{"key":"53814_CR22","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1111\/jocn.14982","volume":"28","author":"C King","year":"2019","unstructured":"King, C., Grandison, T., Cawthorne, J. & Currie, K. Patient experience of hospital screening for carbapenemase-producing Enterobacteriaceae: A qualitative study. J. Clin. Nurs. 28, 3890\u20133900 (2019).","journal-title":"J. Clin. Nurs."},{"key":"53814_CR23","doi-asserted-by":"publisher","DOI":"10.1037\/0000259-000","volume-title":"Interpretative Phenomenological Analysis : Theory, Method and Research","author":"JA Smith","year":"2022","unstructured":"Smith, J. A., Flowers, P. & Larkin, M. Interpretative Phenomenological Analysis\u202f: Theory, Method and Research 2nd edn. (Sage Publications Ltd., 2022).","edition":"2"},{"key":"53814_CR24","volume-title":"Interviews in Qualitative Research","author":"N King","year":"2018","unstructured":"King, N., Horrocks, C. & Brooks, J. Interviews in Qualitative Research 2nd edn. (Sage Publications Ltd., 2018).","edition":"2"},{"key":"53814_CR25","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/13645579.2021.1935565","volume":"25","author":"S Thunberg","year":"2022","unstructured":"Thunberg, S. & Arnell, L. Pioneering the use of technologies in qualitative research\u2014A research review of the use of digital interviews. Int. J. Soc. Res. Methodol. 25, 757\u2013768 (2022).","journal-title":"Int. J. Soc. Res. Methodol."},{"key":"53814_CR26","doi-asserted-by":"publisher","first-page":"e5775","DOI":"10.1111\/hsc.14009","volume":"30","author":"AR Davidson","year":"2022","unstructured":"Davidson, A. R., Morgan, M., Ball, L. & Reidlinger, D. P. Patient advocates\u2019 views of patient roles in interprofessional collaborative practice in primary care: A constructivist grounded theory study. Health Soc. Care Community 30, e5775\u2013e5785 (2022).","journal-title":"Health Soc. Care Community"},{"key":"53814_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/jme.28.1.37","volume":"28","author":"L Schwartz","year":"2002","unstructured":"Schwartz, L. Is there an advocate in the house? The role of health care professionals in patient advocacy. J. Med. Ethics 28, 37\u201340 (2002).","journal-title":"J. Med. Ethics"},{"key":"53814_CR28","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/medu.14408","volume":"55","author":"KA LaDonna","year":"2021","unstructured":"LaDonna, K. A., Watling, C. J., Cristancho, S. M. & Burm, S. Exploring patients\u2019 and physicians\u2019 perspectives about competent health advocacy. Med. Educ. 55, 486\u2013495 (2021).","journal-title":"Med. Educ."},{"key":"53814_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s13187-015-0828-x","volume":"31","author":"TL Hagan","year":"2016","unstructured":"Hagan, T. L. & Medberry, E. Patient education vs. patient experiences of self-advocacy: Changing the discourse to support cancer survivors. J. Cancer Educ. 31, 375\u2013381 (2016).","journal-title":"J. Cancer Educ."},{"key":"53814_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/ijpp\/riaa024","volume":"29","author":"R Emmott","year":"2021","unstructured":"Emmott, R., Barber, S. K. & Thompson, W. Antibiotics and toothache: A social media review. Int. J. Pharm. Pract. 29, 210\u2013217 (2021).","journal-title":"Int. J. Pharm. Pract."},{"key":"53814_CR31","doi-asserted-by":"publisher","first-page":"1184882","DOI":"10.3389\/fpubh.2023.1184882","volume":"11","author":"Y Zheng","year":"2023","unstructured":"Zheng, Y., Liu, J., Tang, P. K., Hu, H. & Ung, C. O. L. A systematic review of self-medication practice during the COVID-19 pandemic: Implications for pharmacy practice in supporting public health measures. Front. Public Health 11, 1184882 (2023).","journal-title":"Front. Public Health"},{"key":"53814_CR32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fpubh.2019.00236","volume":"7","author":"AL Crowe","year":"2019","unstructured":"Crowe, A. L., McKnight, A. J. & McAneney, H. Communication needs for individuals with rare diseases within and around the healthcare system of Northern Ireland. Front. Public Health 7, 236 (2019).","journal-title":"Front. Public Health"},{"key":"53814_CR33","doi-asserted-by":"publisher","first-page":"e060394","DOI":"10.1136\/bmjopen-2021-060394","volume":"12","author":"JC Long","year":"2022","unstructured":"Long, J. C. et al. Needs of people with rare diseases that can be supported by electronic resources: A scoping review. BMJ Open 12, e060394 (2022).","journal-title":"BMJ Open"},{"key":"53814_CR34","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.3399\/bjgp15X685285","volume":"65","author":"G Rowlands","year":"2015","unstructured":"Rowlands, G. et al. A mismatch between population health literacy and the complexity of health information: An observational study. Br. J. Gen. Pract. 65, e379\u2013e386 (2015).","journal-title":"Br. J. Gen. Pract."},{"key":"53814_CR35","doi-asserted-by":"publisher","first-page":"daw003","DOI":"10.1093\/heapro\/daw003","volume":"2016","author":"I Poureslami","year":"2016","unstructured":"Poureslami, I., Nimmon, L., Rootman, I. & Fitzgerald, M. J. Health literacy and chronic disease management: drawing from expert knowledge to set an agenda. Health Promot. Int. 2016, daw003 (2016).","journal-title":"Health Promot. Int."},{"key":"53814_CR36","doi-asserted-by":"publisher","first-page":"e055464","DOI":"10.1136\/bmjopen-2021-055464","volume":"12","author":"C McNulty","year":"2022","unstructured":"McNulty, C., Read, B., Quigley, A., Verlander, N. Q. & Lecky, D. M. What the public in England know about antibiotic use and resistance in 2020: A face-to-face questionnaire survey. BMJ Open 12, e055464 (2022).","journal-title":"BMJ Open"},{"key":"53814_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jacamr\/dlaa067","volume":"2","author":"EM Krockow","year":"2020","unstructured":"Krockow, E. M. Nomen est omen: Why we need to rename \u201cantimicrobial resistance\u201d. JAC Antimicrob. Resist. 2, 1\u20134 (2020).","journal-title":"JAC Antimicrob. Resist."},{"key":"53814_CR38","unstructured":"National Institute for Health and Care Excellence. Healthcare-associated infections: prevention and control [PH36] (2011)."},{"key":"53814_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1046\/j.1523-5394.1999.07206.x","volume":"7","author":"C Krizek","year":"1999","unstructured":"Krizek, C., Roberts, C., Ragan, R., Ferrara, J. J. & Lord, B. Gender and cancer support group participation. Cancer Pract. 7, 86\u201392 (1999).","journal-title":"Cancer Pract."},{"key":"53814_CR40","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/heapro\/dat063","volume":"30","author":"S Ek","year":"2015","unstructured":"Ek, S. Gender differences in health information behaviour: A Finnish population-based survey. Health Promot. Int. 30, 736\u2013745 (2015).","journal-title":"Health Promot. Int."},{"key":"53814_CR41","doi-asserted-by":"publisher","first-page":"888205","DOI":"10.3389\/fpubh.2022.888205","volume":"10","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Disease burden and long-term trends of urinary tract infections: A worldwide report. Front. Public Health 10, 888205 (2022).","journal-title":"Front. Public Health"},{"key":"53814_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1756287219832172","volume":"11","author":"M Medina","year":"2019","unstructured":"Medina, M. & Castillo-Pino, E. An introduction to the epidemiology and burden of urinary tract infections. Ther. Adv. Urol. 11, 3\u20137 (2019).","journal-title":"Ther. Adv. Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53814-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53814-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53814-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T22:03:33Z","timestamp":1707516213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53814-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,10]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53814"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-53814-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,10]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RAH sat on the Public Engagement and Patient Support Committee for Antibiotic Research UK between September 2018 and September 2023. BL, LW, and IW have no relevant declarations. No organisations were involved in the design, undertaking, or reporting of this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3403"}}